@prefix : <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix opv: <http://inab.certh.gr/OpenPVSignal> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix openpvsignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl> .
@base <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl> .

<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl> rdf:type owl:Ontology ;
                                                                                            owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                                        mp: ;
                                                                                            rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/275697/"^^xsd:anyURI ;
                                                                                            rdfs:label "Desogestrel and severe psychiatric disorders: panic attack, suicidal ideation and self-injurious behaviour"^^rdfs:Literal ;
                                                                                            owl:versionInfo "draft-v0.95-20211007"@en .

#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> rdf:type owl:ObjectProperty .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Anxiety
:Anxiety rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F419" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10002855 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Anxiety" ;
         rdfs:label "Anxiety" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Contraception
:Contraception rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "Z30" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10010808 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Contraception" ;
               rdfs:label "Contraception" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Data_pertaining_time_to_onset_for_panic_attacks
:Data_pertaining_time_to_onset_for_panic_attacks rdf:type owl:NamedIndividual ,
                                                          <http://www.w3.org/2006/time#DurationDescription> ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "the panic attacks occurred within the first two months of treatment" ;
                                                 rdfs:label "Data pertaining time to onset for panic attacks" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Data_pertaining_time_to_onset_for_suicidal_ideation-self-injurious_behavior
:Data_pertaining_time_to_onset_for_suicidal_ideation-self-injurious_behavior rdf:type owl:NamedIndividual ,
                                                                                      <http://www.w3.org/2006/time#DurationDescription> ;
                                                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The time to onset (where this information was recorded) ranged from one day to five months" ;
                                                                             rdfs:label "Data pertaining time to onset for suicidal ideation-self-injurious behavior" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#DecreasedLibido
:DecreasedLibido rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R6882" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10024419 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Libido decreased" ;
                 rdfs:label "Decreased libido" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#DepressedMood
:DepressedMood rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F32.9" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10012374 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Depressed mood" ;
               rdfs:label "Depressed mood" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Depression
:Depression rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F32.9" ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10012378 ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Depression" ;
            rdfs:label "Depression" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Depression_listed_in_SmPC
:Depression_listed_in_SmPC rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Structured_Product_Labels_information> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Depression ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
                           rdfs:label "Depression listed in SmPC" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Desogestrel
:Desogestrel rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#hasClass> :Hormonal_Contraceptives_for_Systemic_use ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Mechanism_of_Desogestrel ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03AC09" ;
             rdfs:label "Desogestrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Desogestrel_and_depressed_mood
:Desogestrel_and_depressed_mood rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Warning_Information> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :DecreasedLibido ,
                                                                                                         :DepressedMood ,
                                                                                                         :MoodChanges ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
                                mp:references :Ref.1 ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Listed side effects within the MedDRA system organ class Psychiatric disorders are mood changes, depressed mood and decreased libido. All are considered common." ;
                                rdfs:label "Desogestrel and CNS AE" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Discussion_and_Conclusion
:Discussion_and_Conclusion rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Conclusion> ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Discussion> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The adverse reactions 'mood changes' and 'depressed mood' are listed as common in the ]SmPCs and patient information leaflets for desogestrel. However, the much more severe 'panic attack', 'suicidal ideation' and 'self-injurious behaviour' are not mentioned at all and nothing relevant was found in a PubMed search for desogestrel related to these terms. Although many people feel less depressed and anxious while on contraceptive drugs, some women do suffer from psychiatric problems while starting this type of treatment. That depression is listed in the SmPC does not rule out the possibility that some of these patients might suffer a more severe depression while on desogestrel and that thoughts of self-harm or even suicide could occur. Anxiety may manifest as a symptom of depression and both conditions often occur together. Panic attacks are essentially intensified anxiety that has escalated into intense fear or discomfort. The fact that panic attacks and suicidal ideation are mentioned under post marketing experience for the hormonal contraceptive drug containing ethinylestradiol/iron/ norethisterone and the case reports of another progestin levonorgestrel – causing panic attacks as well as other unlabelled psychiatric problems further strengthen a possible causal relationship between desogestrel and the highlighted adverse reactions. The VigiBase reports contain narratives that describe women with symptoms of both depression, anxiety and panic attacks as well as self-harm. The majority of the reports also mention that the patients improved upon discontinuation of desogestrel. These reports send a strong signal to prescribers to be aware of potentially more severe psychiatric disorders for desogestrel. Further investigations for these type of ADRs for hormonal contraceptives in general would be useful." ;
                           rdfs:label "Discussion and Conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Hormonal_Contraceptives_for_Systemic_use
:Hormonal_Contraceptives_for_Systemic_use rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03A" ;
                                          rdfs:label "Hormonal Contraceptives for Systemic use" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#IC025_of_Hormonal_contraceptives_and_Panic_attack_in_Vigibase
:IC025_of_Hormonal_contraceptives_and_Panic_attack_in_Vigibase rdf:type owl:NamedIndividual ,
                                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :PanicAttack ;
                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :Hormonal_Contraceptives_for_Systemic_use ;
                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :levonorgestrel ,
                                                                                                                              :norethindrone ,
                                                                                                                              :norethindrone-ethinyl_estradiol-iron ,
                                                                                                                              <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#drospirenone/ethinylestradiol> ,
                                                                                                                              <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/etonogestrel> ,
                                                                                                                              <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/norgestimate> ;
                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "positive value >0" ;
                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                               rdfs:label "IC025 of Hormonal contraceptives and Panic attack in Vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#IC025_of_Hormonal_contraceptives_and_suicidal_ideation
:IC025_of_Hormonal_contraceptives_and_suicidal_ideation rdf:type owl:NamedIndividual ,
                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :SuicidalIdeation ,
                                                                                                                                 :self-injuriousBehavior ;
                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1.19 ;
                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                        rdfs:label "IC025 of Hormonal contraceptives and suicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#JudgementImpaired
:JudgementImpaired rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "G3184" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10023236 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Judgement impaired" ;
                   rdfs:label "Judgement impaired" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Literature
:Literature rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Literature_information> ;
            mp:references :Ref.8 ,
                          :Ref.9 ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Although no recorded cases of desogestrel and panic attack, suicidal ideation or self-injurious behaviour were found while searching PubMed, there were several documented cases of psychiatric problems, including panic disorder, in the literature for another progestin – levonorgestrel – from which desogestrel is derived. Wagner et al. described in 1994 two cases of major depression and panic disorder while on levonorgestrel. In 1996 the same author published another article about five women who all developed major depression and where two also developed obsessive-compulsive disorder and one of these women also developed agoraphobia, while using levonorgestrel. These women had no prior psychiatric history and all the ADRs resolved after removal of levonorgestrel.8,9" ;
            rdfs:label "Literature" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Mechanism_of_Desogestrel
:Mechanism_of_Desogestrel rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Mechanism> ;
                          mp:references :Ref.1 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Desogestrel is a hormonal contraceptive progestin drug used to prevent pregnancies. It is used on its own or in combination with ethinylestradiol and marketed in all parts of the world either on its own or as a combination product. The contraceptive effect of desogestrel is, in contrast to traditional progestogen-only pills, achieved primarily by inhibition of ovulation. Other effects include increased viscosity of the cervical mucus and decreased estradiol levels, to a level corresponding to the early follicular phase. Desogestrel is considered to be best suited for use during breast feeding and for women who may not or do not want to use oestrogens.1" ;
                          rdfs:label "Mechanism of Desogestrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#MoodChanges
:MoodChanges rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F39" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10027951 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Mood swings" ;
             rdfs:label "Mood changes" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Natural_and_semisynthetic_estrogens
:Natural_and_semisynthetic_estrogens rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03CA" ;
                                     rdfs:label "Natural and semisynthetic estrogens" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Not_mentionig_ADRs_for_desogestrel
:Not_mentionig_ADRs_for_desogestrel rdf:type owl:NamedIndividual ,
                                             <http://purl.obolibrary.org/obo/OAE_0001182> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "However, the much more severe 'panic attack', 'suicidal ideation' and 'self-injurious behaviour' are not mentioned at all and nothing relevant was found in a PubMed search for desogestrel related to these terms." ;
                                    rdfs:label "Not mentionig ADRs for desogestrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Onset_time_for_Report_1
:Onset_time_for_Report_1 rdf:type owl:NamedIndividual ,
                                  <http://www.w3.org/2006/time#DurationDescription> ;
                         <http://www.w3.org/2006/time#nominalPosition> "days" ;
                         <http://www.w3.org/2006/time#numericPosition> 15 ;
                         rdfs:label "Onset time for Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Onset_time_for_Report_3
:Onset_time_for_Report_3 rdf:type owl:NamedIndividual ,
                                  <http://www.w3.org/2006/time#DurationDescription> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "I did never suspect Cerazette to have any role in my anxiety or panic attacks before I stopped the drug and realized that my problems went away. Thinking back, I realize that my problems started in the same period as I started taking Cerazette" ;
                         rdfs:label "Onset time for Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#PV_Signal
:PV_Signal rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Signal> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> :Discussion_and_Conclusion ,
                                                                                       :Panic_attack_pathophysiology ,
                                                                                       :Reports_in_VigiBase ,
                                                                                       :Suicidal_ideation_pathophysiology ,
                                                                                       :introduction ,
                                                                                       :summary ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_individual_case_report> :Report2 ,
                                                                                                  :Report3 ,
                                                                                                  :Report4 ,
                                                                                                  :Report_1 ,
                                                                                                  :Report_for_suicidal_idealation ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_statistical_entity> :IC025_of_Hormonal_contraceptives_and_Panic_attack_in_Vigibase ,
                                                                                              :IC025_of_Hormonal_contraceptives_and_suicidal_ideation ,
                                                                                              :ReportsWithDesogestrelAsprimary_panicAttack ,
                                                                                              :ReportsWithDesogestrelAsprimary_suicidalIdeation ,
                                                                                              :ReportsWithPatientsWithMedicalHistory ,
                                                                                              :ReportsWithPositivedechallenge_panicAttack ,
                                                                                              :ReportsWithPositivedechallenge_suicidalIdeation ,
                                                                                              :Reports_with_citalopram_as_co-suspect ,
                                                                                              :Reports_with_escitalopram_as_co-suspect ,
                                                                                              :Reports_with_lymecycline_as_co-suspect ,
                                                                                              :Reports_with_other_contraceptives_as_co-suspect ,
                                                                                              :Reports_with_topiramate_as_co-suspect ,
                                                                                              <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&PanicAttack> ,
                                                                                              <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> ,
                                                                                              <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_with_ethinylestradiol/levonorgestrel_as_co-suspect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :PanicAttack ,
                                                                                    :SuicidalIdeation ,
                                                                                    :SuicideAttempts ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :Desogestrel ;
           mp:supportedByData :Depression_listed_in_SmPC ,
                              :Desogestrel_and_depressed_mood ,
                              :Not_mentionig_ADRs_for_desogestrel ,
                              :Positive_IC025_hormonal_contraceptives_and_panic_attack ,
                              :Positive_IC025_hormonal_contraceptives_and_suicidal_ideation ,
                              :Progestogens_and_psychiatric_problems ,
                              :SmPCs_and_PILs_for_desogestrel ,
                              :post_marketing_experience ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#initially_identified_on> "01/11/2018" ;
           rdfs:label "PV Signal" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Panic
:Panic rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F410" ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033670 ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Panic reaction" ;
       rdfs:label "Panic" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#PanicAttack
:PanicAttack rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F410" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033664 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Panic attack" ;
             rdfs:label "Panic attack" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Panic_attack_pathophysiology
:Panic_attack_pathophysiology rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :PanicAttack ;
                              mp:references :Ref.2 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), a panic attack is defined as a discrete period of intense fear or discomfort, often accompanied by physical symptoms such as palpitations and trembling. Experiencing repeated, consistent panic attacks that get in the way of everyday functioning is considered a defining symptom of panic disorder.2" ;
                              rdfs:label "Panic attack pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Panic_attacks_and_disorders
:Panic_attacks_and_disorders rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10068300 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Panic attacks and disorders" ;
                             rdfs:label "Panic attacks and disorders" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Panic_disorder
:Panic_disorder rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033666 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Panic disorder" ;
                rdfs:label "Panic disorder" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Patient_1
:Patient_1 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Patient_2
:Patient_2 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Patient_3
:Patient_3 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Patient_4
:Patient_4 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Patient_with_suicidal_ideation
:Patient_with_suicidal_ideation rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
                                rdfs:label "Patient with suicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Positive_IC025_hormonal_contraceptives_and_panic_attack
:Positive_IC025_hormonal_contraceptives_and_panic_attack rdf:type owl:NamedIndividual ,
                                                                  <http://purl.obolibrary.org/obo/OAE_0001197> ;
                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :PanicAttack ;
                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :Hormonal_Contraceptives_for_Systemic_use ;
                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :levonorgestrel ,
                                                                                                                        :norethindrone ,
                                                                                                                        :norethindrone-ethinyl_estradiol-iron ,
                                                                                                                        <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#drospirenone/ethinylestradiol> ,
                                                                                                                        <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/etonogestrel> ,
                                                                                                                        <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/norgestimate> ;
                                                         mp:references :Ref.6 ;
                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Widening the search to look at all hormonal contraceptives for systemic use (ATC G03A) and the PT 'panic attack' in VigiBase revealed that with several other contraceptives panic attacks were also reported more often than expected compared to the background of the database (i.e. had positive IC025 values; IC025 being the 95% credibility interval for the information component that describes disproportionate reporting in VigiBase6 ). These were drospirenone/ethinylestradiol, ethinylestradiol/etonogestrel, ethinylestradiol/iron/ norethisterone, norethisterone, levonorgestrel and ethinylestradiol/norgestimate." ;
                                                         rdfs:label "Positive IC025 hormonal contraceptives and panic attack" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Positive_IC025_hormonal_contraceptives_and_suicidal_ideation
:Positive_IC025_hormonal_contraceptives_and_suicidal_ideation rdf:type owl:NamedIndividual ,
                                                                       <http://purl.obolibrary.org/obo/OAE_0001197> ;
                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :SuicidalIdeation ,
                                                                                                                                       :self-injuriousBehavior ;
                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :Hormonal_Contraceptives_for_Systemic_use ;
                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ,
                                                                                                                             :norethindrone ,
                                                                                                                             :norethindrone-ethinyl_estradiol-iron ;
                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "An overview of the HLT 'suicidal and self-injurious behaviour' for all systemic hormonal contraceptives in VigiBase showed that desogestrel is one out of three drugs that is reported more often than expected compared to the rest of the database (with a 95% credibility interval: IC025 1.19). The two other drugs both contain norethisterone; the combined oral contraceptive norethisterone acetate/ethinylestradiol/ferrous fumarate and norethisterone alone." ;
                                                              rdfs:label "Positive IC025 hormonal contraceptives and suicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Prevalence_of_suicidal_ideation_among_adolescents
:Prevalence_of_suicidal_ideation_among_adolescents rdf:type owl:NamedIndividual ,
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Prevalence> ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :SuicidalIdeation ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.12 ;
                                                   rdfs:label "Prevalence of suicidal ideation among adolescents" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Progestogens_and_psychiatric_problems
:Progestogens_and_psychiatric_problems rdf:type owl:NamedIndividual ,
                                                <http://purl.obolibrary.org/obo/OAE_0001197> ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Warning_Information> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :DepressedMood ,
                                                                                                                :Depression ,
                                                                                                                :Panic_disorder ,
                                                                                                                :agoraphobia ,
                                                                                                                :obsessive-compulsive_disorder ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :levonorgestrel ;
                                       mp:references :Ref.8 ,
                                                     :Ref.9 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Wagner et al. described in 1994 two cases of major depression and panic disorder while on levonorgestrel. In 1996 the same author published another article about five women who all developed major depression and where two also developed obsessive-compulsive disorder and one of these women also developed agoraphobia, while using levonorgestrel. These women had no prior psychiatric history and all the ADRs resolved after removal of levonorgestrel.8,9" ;
                                       rdfs:label "Wanger et al. report" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.1
:Ref.1 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Electronic Medicines Compendium: Summary of Product Characteristics for desogestrel (Cerazette®) Available from: https://www.medicines.org.uk/emc/ medicine/10098 Accessed: 11 October 2016. " ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.2
:Ref.2 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013. " ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.3
:Ref.3 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Taber’s Online Medical Dictionary. Available from: http://www.tabers.com/tabersonline/ub/ Accessed: 11 October 2016.WHO Pharmaceuticals Newsletter No. 5, 2018 • 16 Signal " ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.4
:Ref.4 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Electronic Medicines Compendium: Summary of Product Characteristics for ethinylestradiol/levonorgestrel (Logynon® ED) Available from: https:// www.medicines.org.uk/emc/medicine/1824 Accessed: 11 October 2016. " ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.5
:Ref.5 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Electronic Medicines Compendium: Summary of Product Characteristics for lymecycline (Tetralysal 300®). Available from: https://www.medicines.org.uk/emc/ medicine/702 Accessed: 11 October 2016. " ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.6
:Ref.6 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Norén GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. Feb 2013;22(1):57- 69. " ;
       rdfs:label "Ref.6" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.7
:Ref.7 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "US DailyMed: Summary of Product Characteristics for ethinylestradiol/iron/norethisterone (Junel® FE24) Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ffbf48de-0f61-49f9- 9cd5-6eb8e08040db&audience=consumer Accessed: 11 October 2016. " ;
       rdfs:label "Ref.7" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.8
:Ref.8 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Wagner KD, Berenson AB. Norplantassociated major depression and panic disorder. J Clin Psychiatry. 1994 Nov;55(11):478-80. 9. Wagner KD. Major depression and anxiety disorders associated with Norplant. J Clin Psychiatry. 1996 Apr;57(4):152-7. " ;
       rdfs:label "Ref.8" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Ref.9
:Ref.9 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Wagner KD. Major depression and anxiety disorders associated with Norplant. J Clin Psychiatry. 1996 Apr;57(4):152-7." ;
       rdfs:label "Ref.9" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Report2
:Report2 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :case_2_info ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Anxiety ,
                                                                                  :PanicAttack ,
                                                                                  :SevereDepression ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient_2 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :Desogestrel ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Report3
:Report3 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :case_3_info ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Anxiety ,
                                                                                  :Panic ,
                                                                                  :PanicAttack ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient_3 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :Desogestrel ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Report4
:Report4 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :case_4_info ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Anxiety ,
                                                                                  :Depression ,
                                                                                  :JudgementImpaired ,
                                                                                  :PanicAttack ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient_4 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :Desogestrel ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_rechallenge_outcome> "positive rechallenge - condition appeared again" ;
         rdfs:label "Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Report_1
:Report_1 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :case_1_info ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :PanicAttack ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient_1 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :Desogestrel ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Onset_time_for_Report_1 ;
          rdfs:label "Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Report_for_suicidal_idealation
:Report_for_suicidal_idealation rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :info_for_report_for_suicidal_idealation ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Anxiety ,
                                                                                                         :SuicidalIdeation ,
                                                                                                         :flashing_images ,
                                                                                                         :insomnia ,
                                                                                                         :intrusive_thoughts ,
                                                                                                         :palpitation ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient_with_suicidal_ideation ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :Desogestrel ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
                                rdfs:label "Report for suicidal idealation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ReportsWithDesogestrelAsprimary_panicAttack
:ReportsWithDesogestrelAsprimary_panicAttack rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&PanicAttack> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :Desogestrel ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 21 ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                             rdfs:label "Reports with desogestrel as primary_panic attack" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ReportsWithDesogestrelAsprimary_suicidalIdeation
:ReportsWithDesogestrelAsprimary_suicidalIdeation rdf:type owl:NamedIndividual ,
                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> ;
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :Desogestrel ;
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 27 ;
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                  rdfs:label "Reports with desogestrel as primary_suicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ReportsWithPatientsWithMedicalHistory
:ReportsWithPatientsWithMedicalHistory rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :Depression ,
                                                                                                                :Panic_disorder ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                       rdfs:label "Reports with patients with medical history" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ReportsWithPositivedechallenge_panicAttack
:ReportsWithPositivedechallenge_panicAttack rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&PanicAttack> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 14 ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
                                            rdfs:label "Reports with positive dechallenge_panic attack" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ReportsWithPositivedechallenge_suicidalIdeation
:ReportsWithPositivedechallenge_suicidalIdeation rdf:type owl:NamedIndividual ,
                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 20 ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
                                                 rdfs:label "Reports with positive dechallenge_suicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_in_VigiBase
:Reports_in_VigiBase rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> ;
                     mp:references :Ref.4 ,
                                   :Ref.5 ,
                                   :Ref.6 ,
                                   :Ref.7 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Panic attacks In VigiBase there were 18 reports for the MedDRA preferred term (PT) 'panic attack' reported for desogestrel as of 1 November 2016. Widening the search to look at all reports within the high level term (HLT) 'panic attacks and disorders' revealed five more reports which are also included in this assessment and gives 23 reports in total. The reports are all from Europe and concern women between the ages of 22 to 48 years. In 16 cases desogestrel is the single reported drug and in all but two of the reports desogestrel is the single suspected drug. In both cases where another drug was co-suspected, the other drug seems to have been taken around the same time, but no exact dates were provided. In one of the cases the cosuspect was another contraceptive drug; ethinylestradiol/levonorgestrel and in the other case it was an antibiotic; lymecycline. None of the drugs have 'panic attack' listed as an adverse drug reaction (ADR).4,5 Only one person had a documented medical history of panic attacks but she had not had a panic attack for five years. Fifteen days after starting desogestrel she experienced a panic attack. There are 14 reported positive dechallenges and one mentioning of a rechallenge for psychiatric problems. For all but one report, the panic attacks occurred within the first two months of treatment. Co-reported terms are often anxiety, depression and/or mood swings. One of the women described her suspected adverse reactions as “Severe depression, anxiety and panic attacks. Sought additional treatment for depression/anxiety from general practitioner but symptoms abated once stopped taking Cerazette.” Similarly, another patient reported her panic attacks while on desogestrel and how they disappeared when she stopped taking the drug as “Episodes of anxiety, panic and panic attacks in pressured situations. I connected this to my current life situation before I stopped Cerazette in January 2015. At the same time the panic attacks I anticipated in certain situations did not occur. I did never suspect Cerazette to have any role in my anxiety or panic attacks before I stopped the drug and realized that my problems went away. Thinking back, I realize that my problems started in the same period as I started taking Cerazette.” There is also a report from a woman which describes a rechallenge of this type of symptom: “Depressive episode, anxiety aggravated, judgement impaired and panic attacks. This is the second time I have tried this birth control method, and the second time I have had mental health issues immediately afterwards. It has brought on my depression and anxiety after being free for about 12 months.” 

Widening the search to look at all hormonal contraceptives for systemic use (ATC G03A) and the PT 'panic attack' in VigiBase revealed that with several other contraceptives panic attacks were also reported more often than expected compared to the background of the database (i.e. had positive IC025 values; IC025 being the 95% credibility interval for the information component that describes disproportionate reporting in VigiBase6). These were drospirenone/ethinylestradiol, ethinylestradiol/etonogestrel, ethinylestradiol/iron/ norethisterone, norethisterone, levonorgestrel and ethinylestradiol/norgestimate. For the combination product ethinylestradiol/iron/norethisterone it was found for one of many products that the adverse reactions 'panic attack' as well as 'suicidal ideation' were included in the label as post marketing experience.7 Suicidal ideation and self-injurious behavior. As of 1 November 2016 there were 26 reports for the MedDRA PT 'suicidal ideation' in VigiBase. One of these reports also mentioned panic attacks and are therefore counted twice for both ADRs. Looking at the HLT suicidal and self-injurious behaviour revealed eight more reports with the PTs 'intentional self-injury', 'self-injurious ideation' and 'suicide attempt'. These reports were also included in this assessment. There were no reports of completed suicides. The reports come from women aged between 18 and 51, and all from Europe. Among the 34 reports, 19 had desogestrel as the only reported drug. Desogestrel was the only suspected drug in 27 reports including one of five reported suicide attempts where the patient had ingested several drugs but only desogestrel was reported as suspected for the reaction. The other suspected drugs were other contraceptives for two patients, topiramate in one case, citalopram in one, escitalopram in one and in two cases multiple drugs in two of the suicide attempts. The time to onset (where this information was WHO Pharmaceuticals Newsletter No. 5, 2018 • 15 Signal recorded) ranged from one day to five months. In 20 cases the patients reported a positive dechallenge and in one case there is a mention of a rechallenge, although it is not clear if it was from the same contraceptive drug. In three of the cases there was a recorded medical history of depression, depressive episodes and panic disorder respectively although all had documented positive dechallenges upon removal of desogestrel. One patient detailed her experiences while on desogestrel as follows: “Anxiety, intrusive disturbing thoughts, suicidal ideation. Having always slept well I was suddenly only able to sleep for two or three hours per night. I felt constantly anxious, shaky, palpitations, constantly feeling the need to run away, couldn’t concentrate on work or anything else. Most disturbingly I began to experience sudden vivid flashing images of me harming my young children - this is something I would never ever do and it upset me greatly. I have no history at all of mental health problems. I began to think this might be hormonal because the psychological symptoms were at their worst the day before my period started. This lead me to search the internet (my next step would have been to seek medical help) and I found accounts by other women who had experienced the same while taking Cerazette/Cerelle. I am really shocked by how much better I feel just a couple of days after having stopped taking it.” An overview of the HLT 'suicidal and self-injurious behaviour' for all systemic hormonal contraceptives in VigiBase showed that desogestrel is one out of three drugs that is reported more often than expected compared to the rest of the database (with a 95% credibility interval: IC025 1.19). The two other drugs both contain norethisterone; the combined oral contraceptive norethisterone acetate/ethinylestradiol/ferrous fumarate and norethisterone alone.""" ;
                     rdfs:label "Reports in VigiBase" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_with_citalopram_as_co-suspect
:Reports_with_citalopram_as_co-suspect rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :citalopram ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                       rdfs:label "Reports with citalopram as co-suspect" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_with_escitalopram_as_co-suspect
:Reports_with_escitalopram_as_co-suspect rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :escitalopram ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                         rdfs:label "Reports with escitalopram as co-suspect" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_with_lymecycline_as_co-suspect
:Reports_with_lymecycline_as_co-suspect rdf:type owl:NamedIndividual ,
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&PanicAttack> ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :lymecycline ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                        rdfs:label "Reports with lymecycline as co-suspect" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_with_other_contraceptives_as_co-suspect
:Reports_with_other_contraceptives_as_co-suspect rdf:type owl:NamedIndividual ,
                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :Hormonal_Contraceptives_for_Systemic_use ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 2 ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                 rdfs:label "Reports with other contraceptives as co-suspect" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_with_topiramate_as_co-suspect
:Reports_with_topiramate_as_co-suspect rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :topiramate ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                       rdfs:label "Reports with topiramate as co-suspect" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Sarah_Watson
:Sarah_Watson rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Author> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_affiliation> "Upsalla Monitoring Centre" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_first_name> "Sarah" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_last_name> "Watson" ;
              rdfs:label "Sarah Watson" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#SevereDepression
:SevereDepression rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F33" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10057840 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Major depression" ;
                  rdfs:label "Severe depression" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#SmPCs_and_PILs_for_desogestrel
:SmPCs_and_PILs_for_desogestrel rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Structured_Product_Labels_information> ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Warning_Information> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :DepressedMood ,
                                                                                                         :MoodChanges ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The adverse reactions 'mood changes' and 'depressed mood' are listed as common in the SmPCs and patient information leaflets for desogestrel." ;
                                rdfs:label "SmPCs and PILs for desogestrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#SuicidalIdeation
:SuicidalIdeation rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10042458 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Suicidal ideation" ;
                  rdfs:label "Suicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Suicidal_ideation_pathophysiology
:Suicidal_ideation_pathophysiology rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :SuicidalIdeation ;
                                   mp:references :Ref.3 ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Suicidal ideation could be translated to thoughts of harming oneself or bringing about one’s own death and is most closely associated with major depression or chronic dysphoria. The prevalence is highest among adolescents and the elderly. Among adolescents it is approximately 12%. Symptoms and signs include depression, poor sleep, anxiety, decreased appetite and mood changes. Among adolescents who experience thoughts of suicide, girls and young women suffer about twice as often as boys. About one in three persons who have suicidal ideations actually tries to commit suicide.3" ;
                                   rdfs:label "Suicidal ideation pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#SuicideAttempts
:SuicideAttempts rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "T1491" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10042464 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Suicide attempt" ;
                 rdfs:label "Suicide attempts" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Uppsala_Monitoring_Centre
:Uppsala_Monitoring_Centre rdf:type owl:NamedIndividual ,
                                    <http://www.w3.org/ns/prov#Organization> ;
                           rdfs:label "Uppsala Monitoring Centre" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Usage_of_desogestrel
:Usage_of_desogestrel rdf:type owl:NamedIndividual ,
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Contraception ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
                      rdfs:label "Usage of desogestrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#agoraphobia
:agoraphobia rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10001502 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Agoraphobia" ;
             rdfs:label "agoraphobia" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#case_1_info
:case_1_info rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Only one person had a documented medical history of panic attacks but she had not had a panic attack for five years. Fifteen days after starting desogestrel she experienced a panic attack." ;
             rdfs:label "case 1 info" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#case_2_info
:case_2_info rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "One of the women described her suspected adverse reactions as “Severe depression, anxiety and panic attacks. Sought additional treatment for depression/anxiety from general practitioner but symptoms abated once stopped taking Cerazette.”" ;
             rdfs:label "case 2 info" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#case_3_info
:case_3_info rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Similarly, another patient reported her panic attacks while on desogestrel and how they disappeared when she stopped taking the drug as “Episodes of anxiety, panic and panic attacks in pressured situations. I connected this to my current life situation before I stopped Cerazette in January 2015. At the same time the panic attacks I anticipated in certain situations did not occur. I did never suspect Cerazette to have any role in my anxiety or panic attacks before I stopped the drug and realized that my problems went away. Thinking back, I realize that my problems started in the same period as I started taking Cerazette.”" ;
             rdfs:label "case 3 info" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#case_4_info
:case_4_info rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "There is also a report from a woman which describes a rechallenge of this type of symptom: “Depressive episode, anxiety aggravated, judgement impaired and panic attacks. This is the second time I have tried this birth control method, and the second time I have had mental health issues immediately afterwards. It has brought on my depression and anxiety after being free for about 12 months.”" ;
             rdfs:label "case 4 info" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#citalopram
:citalopram rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06AB04" ;
            rdfs:label "citalopram" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#escitalopram
:escitalopram rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06AB10" ;
              rdfs:label "escitalopram" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#flashing_images
:flashing_images rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10016758 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Flashing vision" ;
                 rdfs:label "flashing images" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#info_for_report_for_suicidal_idealation
:info_for_report_for_suicidal_idealation rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "One patient detailed her experiences while on desogestrel as follows: “Anxiety, intrusive disturbing thoughts, suicidal ideation. Having always slept well I was suddenly only able to sleep for two or three hours per night. I felt constantly anxious, shaky, palpitations, constantly feeling the need to run away, couldn’t concentrate on work or anything else. Most disturbingly I began to experience sudden vivid flashing images of me harming my young children - this is something I would never ever do and it upset me greatly. I have no history at all of mental health problems. I began to think this might be hormonal because the psychological symptoms were at their worst the day before my period started. This lead me to search the internet (my next step would have been to seek medical help) and I found accounts by other women who had experienced the same while taking Cerazette/Cerelle. I am really shocked by how much better I feel just a couple of days after having stopped taking it.”" ;
                                         rdfs:label "info for report for suicidal idealation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#insomnia
:insomnia rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10022437 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Insomnia" ;
          rdfs:label "insomnia" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#intentional_self-injury
:intentional_self-injury rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10022524 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Intentional self-injury" ;
                         rdfs:label "intentional self-injury" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#introduction
:introduction rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Introduction> ;
              mp:references :Ref.1 ,
                            :Ref.2 ,
                            :Ref.3 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The terms panic attack and suicidal ideation were highlighted for the drug desogestrel in the joint UMC/Lareb signal detection sprint on patient reports in October 2016. Desogestrel is a hormonal contraceptive progestin drug used to prevent pregnancies. It is used on its own or in combination with ethinylestradiol and marketed in all parts of the world either on its own or as a combination product. This assessment has focused on the reports in VigiBase, the WHO global database of individual case safety reports, of desogestrel on its own. The contraceptive effect of desogestrel is, in contrast to traditional progestogen-only pills, achieved primarily by inhibition of ovulation. Other effects include increased viscosity of the cervical mucus and decreased estradiol levels, to a level corresponding to the early follicular phase. Desogestrel is considered to be best suited for use during breast feeding and for women who may not or do not want to use oestrogens.1 Listed side effects within the MedDRA system organ class Psychiatric disorders are mood changes, depressed mood and decreased libido. All are considered common.1 There is however nothing in the summary of product characteristics (SmPCs) or patient information leaflets about anxiety, more severe anxiety leading to panic attacks, or about risks of severe depression leading to suicidal thoughts or suicide attempts, as seen in the reports from patients in VigiBase. According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), a panic attack is defined as a discrete period of intenseWHO Pharmaceuticals Newsletter No. 5, 2018 • 14 Signal fear or discomfort, often accompanied by physical symptoms such as palpitations and trembling. Experiencing repeated, consistent panic attacks that get in the way of everyday functioning is considered a defining symptom of panic disorder.2 Suicidal ideation could be translated to thoughts of harming oneself or bringing about one’s own death and is most closely associated with major depression or chronic dysphoria. The prevalence is highest among adolescents and the elderly. Among adolescents it is approximately 12%. Symptoms and signs include depression, poor sleep, anxiety, decreased appetite and mood changes. Among adolescents who experience thoughts of suicide, girls and young women suffer about twice as often as boys. About one in three persons who have suicidal ideations actually tries to commit suicide.3" ;
              rdfs:label "introduction" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#intrusive_thoughts
:intrusive_thoughts rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10077275 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Intrusive thoughts" ;
                    rdfs:label "intrusive thoughts" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#levonorgestrel
:levonorgestrel rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#hasClass> :Hormonal_Contraceptives_for_Systemic_use ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03AD01 " ;
                rdfs:label "levonorgestrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#lymecycline
:lymecycline rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01AA04 " ;
             rdfs:label "lymecycline" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#norethindrone
:norethindrone rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03DC02" ;
               rdfs:label "norethindrone" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#norethindrone-ethinyl_estradiol-iron
:norethindrone-ethinyl_estradiol-iron rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#hasClass> :Hormonal_Contraceptives_for_Systemic_use ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03AA05" ;
                                      rdfs:label "norethindrone / ethinyl estradiol / iron" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#obsessive-compulsive_disorder
:obsessive-compulsive_disorder rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029898 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Obsessive-compulsive disorder" ;
                               rdfs:label "obsessive-compulsive disorder" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#palpitation
:palpitation rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033556 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Palpitation" ;
             rdfs:label "palpitation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#post_marketing_experience
:post_marketing_experience rdf:type owl:NamedIndividual ,
                                    <http://purl.obolibrary.org/obo/OAE_0001197> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :PanicAttack ,
                                                                                                    :SuicidalIdeation ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :Hormonal_Contraceptives_for_Systemic_use ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :levonorgestrel ,
                                                                                          :norethindrone-ethinyl_estradiol-iron ;
                           mp:references :Ref.7 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The fact that panic attacks and suicidal ideation are mentioned under post marketing experience for the hormonal contraceptive drug containing ethinylestradiol/iron/ norethisterone and the case reports of another progestin levonorgestrel – causing panic attacks as well as other unlabelled psychiatric problems further strengthen a possible causal relationship between desogestrel and the highlighted adverse reactions." ;
                           rdfs:label "post marketing experience" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#self-injuriousBehavior
:self-injuriousBehavior rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "Z91.5" ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 20000037 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Suicide/self-injury" ;
                        rdfs:label "self-injurious behavior " .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#self-injurious_ideation
:self-injurious_ideation rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10051154 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Self-injurious ideation" ;
                         rdfs:label "self-injurious ideation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#summary
:summary rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Summary> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "“Tried antidepressants on three occasions without success and sought months of therapy including cognitive behavioural therapy. Severe depression, high anxiety and suicidal thoughts. Changed to combined contraceptive pill and feel better.” Altered and depressed mood are listed adverse drug reactions (ADRs) for the contraceptive drug desogestrel, but the more severe reactions – suicidal ideation and panic attack – are not. These ADRs were highlighted as potential adverse drug reactions for desogestrel in the joint UMC/Lareb signal detection sprint on patient reports in October 2016. As on 1 November 2016, VigiBase, the WHO global database of individual case safety reports, contained 23 reports of panic attacks of which 21 had desogestrel as the only suspected drug and in 14 of the reports it was documented that the patients improved when the drug was withdrawn. For suicidal and self-injurious behaviour there were 34 reports of which 22 had desogestrel as the only suspected drug, and there were 20 cases describing improvement after withdrawal of the drug. The cases are further strengthened by the patients’ stories, and send a strong signal to prescribers to be aware of potentially more severe psychiatric disorders for desogestrel and an update of the labelling should be considered." ;
         rdfs:label "summary" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#topiramate
:topiramate rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N03AX11" ;
            rdfs:label "topiramate" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Desogestrel_and_severe_psychiatric_disorders:_panic_attack,_suicidal_ideation_and_self-injurious_behavior
<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Desogestrel_and_severe_psychiatric_disorders:_panic_attack,_suicidal_ideation_and_self-injurious_behavior> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Pharmacovigilance_Signal_Report> ;
                                                                                                                                                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_signal> :PV_Signal ;
                                                                                                                                                                                                     mp:publishedBy :Sarah_Watson ,
                                                                                                                                                                                                                    :Uppsala_Monitoring_Centre ;
                                                                                                                                                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_creation_date> "01/11/2018"^^xsd:date ;
                                                                                                                                                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_overall_conclusion> "causal association most probable" ;
                                                                                                                                                                                                     rdfs:label "Desogestrel and severe psychiatric disorders: panic attack, suicidal ideation and self-injurious behavior" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&PanicAttack
<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&PanicAttack> rdf:type owl:NamedIndividual ,
                                                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Panic_attacks_and_disorders ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Data_pertaining_time_to_onset_for_panic_attacks ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 23 ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_men> 0 ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_women> 23 ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_max_age> 48 ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_min_age> 22 ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_geographical_region> "http://dbpedia.org/resource/Europe" ;
                                                                                                                                 rdfs:label "Overall reports desogestrel & panic attack and disorders" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation
<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&SuicidalIdeation> rdf:type owl:NamedIndividual ,
                                                                                                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :SuicidalIdeation ,
                                                                                                                                                                                                               :SuicideAttempts ,
                                                                                                                                                                                                               :intentional_self-injury ,
                                                                                                                                                                                                               :self-injuriousBehavior ,
                                                                                                                                                                                                               :self-injurious_ideation ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :Desogestrel ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Data_pertaining_time_to_onset_for_suicidal_ideation-self-injurious_behavior ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 34 ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_men> 0 ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_women> 34 ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_max_age> 51 ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_min_age> 18 ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_geographical_region> "http://dbpedia.org/resource/Europe" ;
                                                                                                                                      rdfs:label "Overall reports desogestrel & suicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_with_ethinylestradiol/levonorgestrel_as_co-suspect
<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#Reports_with_ethinylestradiol/levonorgestrel_as_co-suspect> rdf:type owl:NamedIndividual ,
                                                                                                                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#OverallReportsDesogestrel&PanicAttack> ;
                                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> <http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/levonorgestrel> ;
                                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                                                                                                                      rdfs:label "Reports with ethinylestradiol/levonorgestrel as co-suspect" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#drospirenone/ethinylestradiol
<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#drospirenone/ethinylestradiol> rdf:type owl:NamedIndividual ,
                                                                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#hasClass> :Hormonal_Contraceptives_for_Systemic_use ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03AA12" ;
                                                                                                                         rdfs:label "drospirenone/ethinylestradiol" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/etonogestrel
<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/etonogestrel> rdf:type owl:NamedIndividual ,
                                                                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#hasClass> :Hormonal_Contraceptives_for_Systemic_use ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03AC08" ,
                                                                                                                                                                                      "G03CA01" ,
                                                                                                                                                                                      "ethinylestradiol/etonogestrel" ;
                                                                                                                         rdfs:label "ethinylestradiol/etonogestrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/levonorgestrel
<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/levonorgestrel> rdf:type owl:NamedIndividual ,
                                                                                                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#hasClass> :Hormonal_Contraceptives_for_Systemic_use ;
                                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03AA07" ;
                                                                                                                           rdfs:label "ethinylestradiol/levonorgestrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/norgestimate
<http://purl.org/OpenPVSignal/Signals/2018_5_Desogestrel_severe_psychiatric_disorders.owl#ethinylestradiol/norgestimate> rdf:type owl:NamedIndividual ,
                                                                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#hasClass> :Hormonal_Contraceptives_for_Systemic_use ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03AA11" ;
                                                                                                                         rdfs:label "ethinylestradiol/norgestimate" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
